147857-42-9

Basic information

• Product Name: methyl (2R)-2-amino-4-{[(3S)-3-amino-4-methoxy-4-oxobutyl]disulfanyl}butanoate dihydrochloride
• CAS NO: 147857-42-9
• Molecular Weight: 369.334
• Mol File: 147857-42-9.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: methyl (2R)-2-amino-4-{[(3S)-3-amino-4-methoxy-4-oxobutyl]disulfanyl}butanoate dihydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: methyl (2R)-2-amino-4-{[(3S)-3-amino-4-methoxy-4-oxobutyl]disulfanyl}butanoate dihydrochloride(147857-42-9)
• EPA Substance Registry System: methyl (2R)-2-amino-4-{[(3S)-3-amino-4-methoxy-4-oxobutyl]disulfanyl}butanoate dihydrochloride(147857-42-9)

Safety Data

• Hazardous Substances Data: 147857-42-9(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 6027-13-0 L-homocysteine 
• 626-72-2 L-homocystine 
• 130981-51-0 (2S,2'S)-4,4'-disulfanediylbis(2-(tert-butoxycarbonyl)amino)butanoic acid 
• 7093-69-8 4,4'-disulfanediylbis(2-aminobutanoic acid) 
• 462-10-2 DL-homocystine 

Relevant articles and documents

CRYSTALLINE SULFAMIDE COMPOUND

The present application relates to a crystalline sulfamide compound, and in particular relates to a crystalline (S)-N-((S)-1-(2-chlorphenyl)-2-((3,3-difluorocyclobutyl)amido)-2oxoethyl)-2-(4-cyanopyridin-2-base)-N-(3-fluorophenyl)-isothiazolidine-3-formam

COMPOUNDS AS L-CYSTINE CRYSTALLIZATION INHIBITORS AND USES THEREOF

A method of preventing or inhibiting L-cystine crystallization is disclosed, using the compounds of formula I: [in-line-formulae]R1a—[O]v-(-A-L-)m-A-[O]v—R1b [/in-line-formulae] wherein A, L, R1a, R1b, m, and v are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of conditions that are causally related to L-cystine crystallization, such as comprising (but not limited to) kidney stones.

PEPTIDES AS OXYTOCIN AGONISTS

The present compounds are oxytocin receptor agonists for the treatment of autism, stress, including post-traumatic stress disorder, anxiety, including anxiety disorders and depression, schizophrenia, psychiatric disorders and memory loss, alcohol withdraw